...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Human Factor H Interacts Selectively with Neisseria gonorrhoeae and Results in Species-Specific Complement Evasion.
【24h】

Human Factor H Interacts Selectively with Neisseria gonorrhoeae and Results in Species-Specific Complement Evasion.

机译:人因子H与淋病奈瑟菌选择性相互作用,并导致特定物种的补体逃避。

获取原文
获取原文并翻译 | 示例
           

摘要

Complement forms a key arm of innate immune defenses against gonococcal infection. Sialylation of gonococcal lipo-oligosaccharide, or expression of porin 1A (Por1A) protein, enables Neisseria gonorrhoeae to bind the alternative pathway complement inhibitor, factor H (fH), and evade killing by human complement. Using recombinant fH fragment-murine Fc fusion proteins, we localized two N. gonorrhoeae Por1A-binding regions in fH: one in complement control protein domain 6, the other in complement control proteins 18-20. The latter is similar to that reported previously for sialylated Por1B gonococci. Upon incubation with human serum, Por1A and sialylated Por1B strains bound full-length human fH (HufH) and fH-related protein 1. In addition, Por1A strains bound fH-like protein 1 weakly. Only HufH, but not fH from other primates, bound directly to gonococci. Consistent with direct HufH binding, unsialylated Por1A gonococci resisted killing only by human complement, but not complement from other primates, rodents or lagomorphs; adding HufH to these heterologous sera restored serum resistance. Lipo-oligosaccharide sialylation of N. gonorrhoeae resulted in classical pathway regulation as evidenced by decreased C4 binding in human, chimpanzee, and rhesus serum but was accompanied by serum resistance only in human and chimpanzee serum. Direct-binding specificity of HufH only to gonococci that prevents serum killing is restricted to humans and may in part explain species-specific restriction of natural gonococcal infection. Our findings may help to improve animal models for gonorrhea while also having implications in the choice of complement sources to evaluate neisserial vaccine candidates.
机译:补体是针对淋球菌感染的先天免疫防御的重要组成部分。淋球菌脂寡糖的唾液酸化,或孔蛋白1A(Por1A)蛋白的表达,使淋病奈瑟氏球菌能够结合替代途径补体抑制剂H因子(fH),并避免被人补体杀死。使用重组fH片段-鼠Fc融合蛋白,我们在fH中定位了两个淋病奈瑟氏球菌Por1A结合区域:一个位于补体控制蛋白结构域6中,另一个位于补体控制蛋白18-20中。后者与先前报道的唾液酸化的Por1B淋球菌相似。与人血清一起孵育后,Por1A和唾液酸化的Por1B菌株与全长人fH(HufH)和fH相关蛋白1结合。此外,Por1A菌株与fH类蛋白1的结合较弱。仅HufH,而不与其他灵长类动物的fH直接结合到淋球菌。与直接的HufH结合一致,未唾液酸化的Por1A淋球菌仅能抵抗人类补体的杀伤,而不能抵抗其他灵长类,啮齿动物或兔形动物的杀伤。在这些异源血清中加入HufH可恢复血清抵抗力。淋病奈瑟氏球菌的脂寡糖唾液酸化作用导致经典的途径调节,其通过人,黑猩猩和恒河猴血清中C4结合的降低而得以证明,但仅在人和黑猩猩血清中伴随有血清抗性。 HufH仅对阻止血清杀死的淋球菌的直接结合特异性仅限于人类,并且可能部分解释了自然淋球菌感染的物种特异性限制。我们的发现可能有助于改善淋病的动物模型,同时也对评估奈瑟球菌候选疫苗的补体来源的选择有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号